• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.

View in: PubMed

subject areas
  • Allyl Compounds
  • Animals
  • Apoptosis
  • Astrocytes
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Glioblastoma
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases
  • Humans
  • Male
  • Mice, SCID
  • Neurons
  • Sulfides
  • Xenograft Model Antitumor Assays

authors with profiles
  • Libby Kosnik Infinger
  • Scott Michael Lindhorst
  • Arabinda Das
  • David Maria Cachia
  • Narendra L. Banik
  • Sunil J. Patel
  • William Alexander Vandergrift
  • Abhay K. Varma
  • Pierre Giglio